HUMAN VACCINES PROJECT, INC -  

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000

Ranking timeline:

Project Participation Performance(2020-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 1
As coordinator: 0
As participant: 1
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 9.974.294 760.705 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ASA SPEZIALENZYME1
BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE1
EUROVACC FOUNDATION1
FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA1
HELMHOLTZZENTRUM FUR INFEKTIONSFORSCHUNG1
HELSE BERGEN HF1
INDIAN INSTITUTE OF TECHNOLOGY MADRAS1
INSTITUT PASTEUR1
LEIDS UNIVERSITAIR MEDISCH CENTRUM1
NATIONAL INSTITUTE OF IMMUNOLOGY SOCIETY1
PUBLIC HEALTH FOUNDATION OF INDIA1
SETH G S M COLLEGE AND K E M HOSPITAL DIAMOND JUBILEE SOCIETY1
STICHTING CENTRE FOR HUMAN DRUG RESEARCH1
STICHTING HUMAN VACCINES PROJECT EUROPE1
TRANSLATIONAL HEALTH SCIENCE AND TECHNOLOGY INSTITUTE1
UGA RESEARCH FOUNDATION INC NON PROFIT CORP1
UNIVERSITE LIBRE DE BRUXELLES1
UNIVERSITEIT ANTWERPEN1
UNIVERSITY OF BERGEN1
UNIVERSITY OF OSLO1

Constancy:

Total number of partners: 20
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 20
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2020-08-01Indo-European Consortium for Next Generation Influenza Vaccine Innovation INCENTIVEparticipant9.974.29421